Cipher Pharmaceuticals Schedules Q2 2022 Earnings Release and Conference Call
05 August 2022 - 9:00PM
PR Newswire (Canada)
MISSISSAUGA, ON, Aug. 5, 2022
/CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) ("Cipher" or
"the Company") today announced that it will release its Q2
2022 financial results on Thursday, August
11, 2022 after market close. The Company will also host a
conference call on Friday, August 12,
2022 at 8:30am ET to discuss
the results and corporate developments.
CONFERENCE CALL DETAILS
DATE:
|
August 12,
2022
|
|
|
TIME:
|
8:30 a.m. ET
|
|
|
DIAL-IN
NUMBER:
|
(647) 484-0475 or (888)
220-8451
|
|
|
CONFERENCE
ID:
|
7538758
|
|
|
REPLAY
DIAL-IN:
|
(888) 203-1112
(playback 7538758#)
|
|
Expires August 19,
2022
|
|
|
WEBCAST:
|
https://app.webinar.net/871ZpObNzYX
|
About Cipher Pharmaceuticals
Inc.
Cipher Pharmaceuticals (TSX: CPH) is a specialty pharmaceutical
company with a robust and diversified portfolio of commercial and
early to late-stage products. Cipher acquires products that fulfill
unmet medical needs, manages the required clinical development and
regulatory approval process, and currently markets those products
either directly in Canada or indirectly through partners
in Canada, the U.S., and South America. For more
information, visit www.cipherpharma.com.
SOURCE Cipher Pharmaceuticals Inc.
Copyright 2022 Canada NewsWire
Cipher Pharmaceuticals (TSX:CPH)
Historical Stock Chart
From Apr 2024 to May 2024
Cipher Pharmaceuticals (TSX:CPH)
Historical Stock Chart
From May 2023 to May 2024